Kusajili – Clinical trials directory

Result of your search per sponsor: Beaufour Ipsen Pharma - 24, rue Erlanger 75016 Paris FRANCE

Man Max 99 years
Beaufour Ipsen Pharma - 24, rue Erlanger 75016 Paris FRANCE Update Il y a 4 ans

A phase II, open-label, multicentre study to evaluate the pharmacodynamic profile, the efficacy and the safety of a 6-month sustained-release formulation of triptorelin in patients with prostate cancer To evaluate the pharmacodynamic profile of a 6-month sustained-release formulation of triptorelin administered as two simultaneous subcutaneous microimplant injections (2x6 mg) by measuring serum test...

Country None
organs None
Specialty None

Closed trial

More information